Solving adherence issues with prodrugs, examining whether PBMs are to blame for high drugs prices in the US, developing ...

As the approval date for Bristol Myers Squibb’s schizophrenia drug KarXT looms, a prodrug approach emerges to potentially ...

Join us for the final broadcast of this year's symposium as John Higgins explains how prodrugs can be pursued early in discovery space in order to optimize drugs’ physicochemical and biopharmaceutical ...

Experiments in which they tested the effectiveness of activating the prodrugs in cell culture on colon and prostrate cancer cells showed the antibody to be effective at therapeutically relevant ...

H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Zevra Therapeutics (ZVRA – Research Report) today and set a price target ...

Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop ...

Medivir is developing tumor-directed nucleotide oral prodrugs to treat cancers with highly unmet medical needs. The company’s lead drug candidate, MIV-818, is a liver cancer targeted prodrug ...

The primary endpoint of the SUNRISE-3 trial was all-cause hospitalization or death through Day 29 in the supportive care monotherapy cohort. In addition, secondary endpoints measured patient outcomes ...

From spoiled meat to seaweed and secure software – a wide range of University of Otago research projects have secured $8 ...

development of new imaging and therapeutic agents towards cancer and cardiovascular disease; Design and synthesis of novel prodrugs of peptides and peptide mimetics.

Detailed price information for Thiogenesis Therapeutics Corp (TTI-X) from The Globe and Mail including charting and trades.

- Collaboration to leverage AbbVie's eye care expertise and Ripple's innovative drug delivery platform to develop next-generation sustained release drug delivery implants for the treatment of glaucoma ...